Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT03136133 |
Date of registration:
|
27/04/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Protein Supplements to Cyclists
|
Scientific title:
|
Effekt of Marine Peptide Supplementation on Recovery Following Endurance Cycling |
Date of first enrolment:
|
September 14, 2017 |
Target sample size:
|
16 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03136133 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Single (Participant).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Norway
| | | | | | | |
Contacts
|
Name:
|
Trygve Hausken, MD |
Address:
|
|
Telephone:
|
+4755972134 |
Email:
|
trygve.hausken@helse-bergen.no |
Affiliation:
|
|
|
Name:
|
Trygve Hausken, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Signed informed Consent
- The subject is a man between 40-50 years
- The subject has a body mass index (BMI) between 19-29
- Willing to comply with all study procedures and be available for the length of the
study
- In good general health as judged by the physician at the screening visit
Exclusion Criteria:
- The subject has had surgery or trauma with significant blood loss or has donated blood
within the last 3 months prior to the screening visit
- Diabetes type 1 or 2, or persistent high blood sugar levels
- The subject has tested positive for human immunodeficiency virus (HIV)
- Hepatitis B surface antigen (HBsAg), or hepatitis C virus antibody (anti-HCV)
- The subject has taken any investigational drugs within 1 month prior to screening
- Treated with antibiotics within 3 months prior to screening (oral, parenteral or
rectal), but not spray or ointment
- Treated with steroids within 1 month prior to screening (including oral treatment)
- Treated with medication that effects the intestinal function such as, H2- protonpump
inhibitors, diuretics, antiemetics, antidepressants, antacids,
Age minimum:
40 Years
Age maximum:
50 Years
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
Reconstitution After Bicycle Intervention
|
Intervention(s)
|
Dietary Supplement: Active protein drink
|
Primary Outcome(s)
|
Change in blood glucose compared to placebo
[Time Frame: Change from baseline to every 30 minutes after dosing, for 2 hours]
|
Secondary Outcome(s)
|
Change in insulin-like peptide 5 compared to placebo
[Time Frame: Change from baseline to every 30 minutes after dosing, for 2 hours]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|